Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.29

VIR Q4 2018 Earnings — Vir Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

VIRVir Biotechnology, Inc.

$1B

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6,000

Gross Profit

-$24M-396950.0% margin

Operating Income

-$27M-446600.0% margin

Net Income

-$26M-439883.3% margin

EPS (Diluted)

$-0.27

QoQ Revenue Growth

-94.7%

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$32M

Stock-Based Comp.

$952,000

Balance Sheet

Total Assets

$192M

Total Liabilities

$371M

Stockholders' Equity

-$179M

Cash & Equivalents

$48M

← FY 2018 All Quarters Q1 2019 →